Primary Causes & Pathophysiology
Microorganisms typically enter the lower respiratory tract via microaspiration of oropharyngeal secretions, inhalation of contaminated aerosols, or haematogenous spread from a distant source. Once in the alveoli, pathogens multiply and trigger an intense host inflammatory response mediated by alveolar macrophages and the release of pro-inflammatory cytokines (such as IL-1 and TNF-alpha). This inflammation causes increased pulmonary capillary permeability, leading to the exudation of protein-rich fluid, neutrophils, and erythrocytes into the alveolar spaces. This process of hepatisation (consolidation) impairs alveolar gas exchange, resulting in ventilation-perfusion mismatch and clinically apparent hypoxaemia.
A Gram-positive diplococcus possessing a polysaccharide capsule that evades host phagocytosis, representing the most common typical bacterial cause of community-acquired pneumonia.
An atypical bacterium lacking a cell wall that binds directly to respiratory epithelium via P1 adhesin, often causing prolonged, milder community outbreaks, particularly in younger patients.
A Gram-positive coccus that can cause severe necrotising pneumonia, frequently occurring as a secondary bacterial complication following influenza virus infection or in healthcare-associated settings.
A Gram-negative coccobacillus that is particularly common as a causative agent in patients with underlying structural lung disease, such as COPD or bronchiectasis.
Pathogens that cause direct viral infection and cytopathic destruction of the respiratory epithelium, which drives intense lung inflammation and predisposes the damaged mucosa to secondary bacterial invasion.